Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
13
×
boston blog main
boston top stories
national top stories
clinical trials
national
biotech
new york top stories
boston
new york blog main
san diego blog main
san diego top stories
san francisco top stories
drugs
fda
precision medicine
san francisco blog main
genomics
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
exome
financing
indiana blog main
indiana top stories
life science
raleigh-durham blog main
raleigh-durham top stories
roche
san diego
seattle blog main
seattle top stories
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
What
medicine
new
13
×
drug
approved
fda
cancer
data
genetic
genomics
precision
biotech
cells
depression
event
known
making
oks
podcast
red
san
second
advance
aldeyra
alnylam
ambitious
anemia
approach
atrophy
bags
biotechs
blood
body
brexanolone
building
capital
carry
cas
centers
chunk
cleared
Language
unset
Current search:
medicine���s
×
new
×
" national blog main "
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
Explore San Diego’s Precision Medicine and Genomics Sector in Xconomy’s New Podcast and Special Report
@xconomy.com
4 years ago
Podcast: How San Diego is Building a Biotech Ecosystem – Genomics & Precision Medicine Experts Weigh in
@xconomy.com
4 years ago
VenBio Partners Bags $394M to Back More Medicine-Making Biotechs
@xconomy.com
4 years ago
Disc Medicine Launches With $50M to Advance New Anemia Treatments
@xconomy.com
5 years ago
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Ireland to Sequence 400K Genomes With New Precision Medicine Effort
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
@xconomy.com
5 years ago
Will New Study Cut Guesswork for Depression Medicine Prescriptions?